Planned equivalence or noninferiority trials versus unplanned noninferiority claims: are they equal?

J Clin Oncol. 2006 Mar 1;24(7):1026-8. doi: 10.1200/JCO.2005.04.9684.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anemia, Hypochromic / chemically induced
  • Anemia, Hypochromic / drug therapy*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Confidence Intervals
  • Disease Progression
  • Drug Administration Schedule
  • Epoetin Alfa
  • Erythropoietin / administration & dosage*
  • Female
  • Hematinics / administration & dosage*
  • Humans
  • Male
  • Odds Ratio
  • Ovarian Neoplasms / drug therapy
  • Prostatic Neoplasms / drug therapy
  • Quality of Life
  • Randomized Controlled Trials as Topic
  • Recombinant Proteins
  • Survival Analysis
  • Therapeutic Equivalency*
  • Treatment Outcome

Substances

  • Hematinics
  • Recombinant Proteins
  • Erythropoietin
  • Epoetin Alfa